This page is dedicated to the 30mg product presentation
A mitochondria-to-nucleus regulation mediated by the nuclear-translocated mitochondrial lncRNAs
The trial was terminated early due to sponsor strategic considerations after enrolling only 23 of the planned participants, completing in November 2022, with results showing the compound was well-tolerated but efficacy data limited due to early termination and small sample size
A healthcare provider should review kidney history, including kidney stones, G6PD deficiency, diabetes, anticoagulant use, sodium restrictions and other relevant health factors before prescribing injectable ascorbic acid
The resulting serum is crystal clear and effective
Researchers can perform serial dilutions, dose-response experiments, and long-duration protocols without repeatedly preparing fresh solutions